ConductScience.org, home

Paper42043964

MAP17 Enhances Chemoresistance and Tumorigenicity of Glioblastoma-Initiating Cells via the Canonical NF-кB Pathway.

Dou S and 2 others. Cancer Sci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. MAP17 Enhances Chemoresistance and Tumorigenicity of Glioblastoma-Initiating Cells via the Canonical NF-кB Pathway. Papers, record 42043964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42043964

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MAP17 Enhances Chemoresistance and Tumorigenicity of Glioblastoma-Initiating Cells via the Canonical NF-кB Pathway.
PubMed
Journal
Cancer Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dou SShenshen
2Son YLYou Leehttps://orcid.org/0000-0002-3429-5324
3Kondo TToru

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Drug Resistance, NeoplasmMajor topic
Brain NeoplasmsMajor topic
NF-kappa BMajor topic
Neoplastic Stem CellsMajor topic
Microtubule-Associated ProteinsMajor topic
Humans
Temozolomide
Animals
Cell Line, Tumor
Signal Transduction
Proto-Oncogene Proteins c-bcl-2
Dacarbazine
Cell Proliferation
Antineoplastic Agents, Alkylating
Mice
Transcription Factor RelA
Gene Expression Regulation, Neoplastic
Apoptosis
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
17ck0106236h0002AMED Practical Research for Innovative Cancer ControlPubMed
20H03559JSPS KAKENHI Grant-in-Aid for Scientific ResearchPubMed
21K06240JSPS KAKENHI Grant-in-Aid for Scientific ResearchPubMed
24K09511JSPS KAKENHI Grant-in-Aid for Scientific ResearchPubMed
The Joint Research Program of the Institute for Genetic Medicine Hokkaido UniversityPubMed

Source PubMed

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133495554Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL.Cell Death Differ2021https://conductscience.org/library/papers/33495554PubMed
232464096The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.Cell Stem Cell2020https://conductscience.org/library/papers/32464096PubMed
329511297Ecrg4 peptide is the ligand of multiple scavenger receptors.Sci Rep2018https://conductscience.org/library/papers/29511297PubMed
436853018Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.Cancer Sci2023https://conductscience.org/library/papers/36853018PubMed
512771129Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins.J Cell Biol2003https://conductscience.org/library/papers/12771129PubMed
623418532MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival.PLoS One2013https://conductscience.org/library/papers/23418532PubMed
719269895Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.Lancet Oncol2009https://conductscience.org/library/papers/19269895PubMed
812001991NF-kappaB in cancer: from innocent bystander to major culprit.Nat Rev Cancer2002https://conductscience.org/library/papers/12001991PubMed
916632342Brain cancer stem-like cells.Eur J Cancer2006https://conductscience.org/library/papers/16632342PubMed
1017675338MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation.Carcinogenesis2007https://conductscience.org/library/papers/17675338PubMed
1133453403Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic/epigenetic mutation and microenvironment.Semin Cancer Biol2022https://conductscience.org/library/papers/33453403PubMed
1234109179Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression.Front Cell Dev Biol2021https://conductscience.org/library/papers/34109179PubMed
1324355989Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.Nat Rev Mol Cell Biol2014https://conductscience.org/library/papers/24355989PubMed
1411704864Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer.Oncogene2001https://conductscience.org/library/papers/11704864PubMed
1531499527Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.Neuro Oncol2020https://conductscience.org/library/papers/31499527PubMed
1627090194Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating Cells.Stem Cells2016https://conductscience.org/library/papers/27090194PubMed
1734337348Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.Cancer Drug Resist2021https://conductscience.org/library/papers/34337348PubMed
1820129251Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.Cancer Cell2010https://conductscience.org/library/papers/20129251PubMed
1916926447Interaction of MAP17 with NHERF3/4 induces translocation of the renal Na/Pi IIa transporter to the trans-Golgi.Am J Physiol Renal Physiol2007https://conductscience.org/library/papers/16926447PubMed
2040805270Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels.Cancers (Basel)2025https://conductscience.org/library/papers/40805270PubMed

See all 50 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PDZK1IP110158PubTator's text mininghttps://conductscience.org/library/genes/10158NCBI Gene
RELA5970PubTator's text mininghttps://conductscience.org/library/genes/5970NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42043964

GET https://conductscience.org/api/papers/v1/42043964/references?page=2